Peru vs Tajikistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Peru
80.0%
in 2025
Tajikistan
79.0%
in 2025
Peru rank
116th
Tajikistan rank
119th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Peru
- Tajikistan
How they compare
Peru currently reports 80.0% against 79.0% in Tajikistan, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Tajikistan ahead.
Peru ranks 116th and Tajikistan ranks 119th of 192 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Peru | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.5% | 0.0% | 4.5% | Peru |
| 2010s | 83.7% | 0.0% | 83.7% | Peru |
| 2020s | 76.7% | 31.3% | 45.3% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Peru or Tajikistan?
- Peru, at 80.0% against 79.0% in Tajikistan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Peru and Tajikistan?
- 1.0%, with Peru ahead.
- How many years of comparable data are there for Peru and Tajikistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Peru and Tajikistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Peru ranks 116th and Tajikistan ranks 119th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.